In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy

Ann Intern Med. 2020 Dec 15;173(12):JC71. doi: 10.7326/ACPJ202012150-071.


Hopewell JC, Offer A, Haynes R, et al. Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom. Eur Heart J. 2020;41:3336-42. 32702748.

Publication types

  • Comment

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Muscles
  • Muscular Diseases* / chemically induced
  • Risk Factors
  • Simvastatin / adverse effects


  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Simvastatin